NCT06817096View on ClinicalTrials.gov

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

340

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Covid 19Influenza

Interventions

DRUG

Nitazoxanide 600Mg Oral Tablet / placebo oral tablet

1 tablet every 12 hours

All Listed Sponsors

collaborator

Farmoquimica S.A.

INDUSTRY

lead

Azidus Brasil

INDUSTRY